CEL-SCI Corp. (CVM)
1.21
-0.26
(-17.69%)
USD |
NYAM |
Nov 20, 16:00
1.20
-0.01
(-0.83%)
Pre-Market: 20:00
CEL-SCI Price to Book Value : 1.943 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.943 |
| November 19, 2026 | 2.36 |
| November 18, 2026 | 2.216 |
| November 17, 2026 | 2.97 |
| November 16, 2026 | 2.665 |
| November 13, 2026 | 2.055 |
| November 12, 2026 | 1.910 |
| November 11, 2026 | 2.103 |
| November 10, 2026 | 2.264 |
| November 09, 2026 | 2.167 |
| November 06, 2026 | 2.328 |
| November 05, 2026 | 2.199 |
| November 04, 2026 | 2.216 |
| November 03, 2026 | 2.264 |
| November 02, 2026 | 2.103 |
| October 30, 2026 | 2.216 |
| October 29, 2026 | 2.408 |
| October 28, 2026 | 2.569 |
| October 27, 2026 | 2.520 |
| October 26, 2026 | 2.553 |
| October 23, 2026 | 2.633 |
| October 22, 2026 | 2.585 |
| October 21, 2026 | 2.601 |
| October 20, 2026 | 2.488 |
| October 19, 2026 | 2.649 |
| Date | Value |
|---|---|
| October 16, 2026 | 2.874 |
| October 15, 2026 | 2.793 |
| October 14, 2026 | 2.745 |
| October 13, 2026 | 2.810 |
| October 12, 2026 | 2.938 |
| October 09, 2026 | 3.114 |
| October 08, 2026 | 3.131 |
| October 07, 2026 | 3.420 |
| October 06, 2026 | 4.399 |
| October 05, 2026 | 3.885 |
| October 02, 2026 | 3.708 |
| October 01, 2026 | 3.355 |
| September 30, 2026 | 3.307 |
| September 29, 2026 | 2.874 |
| September 28, 2026 | 2.729 |
| September 25, 2026 | 2.681 |
| September 24, 2026 | 2.761 |
| September 23, 2026 | 2.697 |
| September 22, 2026 | 2.729 |
| September 21, 2026 | 2.681 |
| September 18, 2026 | 2.665 |
| September 17, 2026 | 2.392 |
| September 16, 2026 | 2.376 |
| September 15, 2026 | 2.376 |
| September 14, 2026 | 2.440 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 16.42 |
| Anika Therapeutics, Inc. | 1.288 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.268 |
Price to Book Value Related Metrics
| Price | 1.21 |
| Earnings Yield | -213.5% |
| Market Cap | 21.28M |